Purdue Pharma L.P.
Purdue Pharma L.P., a prominent player in the pharmaceutical industry, is headquartered in the United States. Founded in 1892, the company has established itself as a leader in pain management and addiction treatment, with a focus on developing innovative therapies. Purdue Pharma is best known for its flagship product, OxyContin, which revolutionised pain relief but also sparked significant discussions around opioid use and addiction. With a commitment to addressing public health challenges, Purdue Pharma has expanded its portfolio to include a range of medications aimed at treating various conditions, including opioid use disorder. The company has made notable strides in research and development, positioning itself as a key contributor to the ongoing dialogue about responsible pain management. Through its dedication to improving patient outcomes, Purdue Pharma continues to navigate the complexities of the pharmaceutical landscape.
DitchCarbon Score
How does Purdue Pharma L.P.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Purdue Pharma L.P.'s score of 23 is lower than 77% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Purdue Pharma L.P.'s reported carbon emissions
Purdue Pharma L.P., headquartered in the US, currently does not report any carbon emissions data, as indicated by the absence of specific figures in kg CO2e. Additionally, there are no documented reduction targets or climate pledges associated with the company. This lack of data suggests that Purdue Pharma may not have established formal commitments to address carbon emissions or climate change initiatives at this time. As such, the company does not inherit any emissions data or targets from a parent organisation, nor does it participate in recognised climate initiatives like the Science Based Targets initiative (SBTi) or the Carbon Disclosure Project (CDP).
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Purdue Pharma L.P. is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
